Synergistic effect of nitric oxide and vasoactive intestinal peptide on bronchoprotection against histamine in anesthetized guinea pigs

American Journal of Respiratory and Critical Care Medicine

Volumn 155, Issue 2, 1997, Pages 747-750

  Kanazawa, Hiroshi ^a   Kawaguchi, Takashi ^a   Shoji, Seiichi ^a   Fujii, Tatsuo ^a   Kudoh, Shinzoh ^a   Hirata, Kazuto ^a   Kurihara, Naotsugu ^a   Yoshikawa, Junichi ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HISTAMINE; N ACETYL S NITROSOPENICILLAMINE; NITRIC OXIDE; UNCLASSIFIED DRUG; VASOACTIVE INTESTINAL POLYPEPTIDE; VASOACTIVE INTESTINAL POLYPEPTIDE AGONIST;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRONCHOSPASM; CONTROLLED STUDY; DOSE RESPONSE; DRUG POTENTIATION; GUINEA PIG; HISTAMINE RELEASE; LUNG INJURY; LUNG RESISTANCE; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL;

EID: 0031051812     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.155.2.9032223     Document Type: Article

References (23)

1. Barnes, P. J. 1986. Neural control of human airways in health and disease. Am. Rev. Respir. Dis. 134:1289-1314.
2. Matsuzaki, Y., Y. Hamasaki, and S. I. Said. 1980. Vasoactive intestinal polypeptide: a possible neurotransmitter of non-adrenergic relaxation of guinea pig airways. Science 210:1252-1253.
3. Ellis, J. L., and S. G. Farmer. 1989. The effects of VIP antagonists, and VIP and PHI antisera on non-adrenergic, non-cholinergic relaxations of tracheal smooth muscle. Br. J. Pharmacol. 96:513-520.
4. Ellis, J. L., and S. G. Farmer. 1989. Effects of peptidases on non-adrenergic, non-cholinergic inhibitory response to tracheal smooth muscle: a comparison with effects on VIP- and PHI-induced relaxation. Br. J. Pharmacol. 96:521-526.
5. Moncada, S., E. A. Higgs, H. F. Hodson, R. G. Knowles, P. Lopez-Jaramillo, T. McCall, R. M. J. Palmer, M. W. Radomski, D. D. Ress, and R. Shultz. 1990. The L-arginine: nitric oxide pathway. J. Cardiovasc. Pharmacol. 17:S1-9.
6. Li, S. G., and M. J. Rand. 1991. Evidence that part of the NANC relaxant response of guinea-pig trachea to electrical field stimulation is mediated by nitric oxide. Br. J. Pharmacol. 102:91-94.
7. Belvisi, M. G., C. D. Stretton, M. Yacoub, and P. J. Barnes. 1992. Nitric oxide is the endogenous neurotransmitter of bronchodilator nerves in humans. Eur. J. Pharmacol. 210:221-222.
8. Tsukahara, H., D. V. Gordienko, and M. S. Goligorsky. 1993. Continuous monitoring of nitric oxide release from human umbilical vein endothelial cells. Biochem. Biophys. Res. Commun. 193:722-729.
9. Dusser, D. J., E. Umeno, P. D. Graf, T. Djokic, D. B. Borson, and J. A. Nadel. 1988. Airway neutral endopeptidase-like enzyme modulates tachykinin-induced bronchoconstriction in vivo. J. Appl. Physiol. 65:2585-2591.
10. Barnes, P. J., and M. G. Belvisi. 1993. Nitric oxide and lung disease. Thorax 48:1034-1043.
11. Nijkamp, F. P., and G. Folkerts. 1994. Nitric oxide and bronchial reactivity. Clin. Exp. Allergy 24:905-914.
12. Palmer, J. B., F. M. C. Cuss, and P. J. Barnes. 1986. VIP and PHM and their role in non-adrenergic inhibitory responses in isolated human airways. J. Appl. Physiol. 61:1322-1328.
13. Heaship, R. J., F. R. Giesa, T. J. Rimele, and D. Grimes. 1987. Coregulation of tracheal tone by cyclic AMP- and cyclic GMP-dependent mechanism. J. Pharmacol. Exp. Ther. 243:1018-1026.
14. Said, S. I. 1992. Nitric oxide and vasoactive intestinal peptide: cotransmitters of smooth muscle relaxation. News Physiol. Sci. 7:181-183.
15. Bearo, J. A., and D. H. Reifsnyder. 1990. Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors. Trends Pharmacol. Sci. 11:150-155.
16. Torphy, T. J., B. J. Undem, L. B. Cieslinski, M. A. Luttmann, M. L. Reeves, and D. W. P. Hay. 1993. Identification, characterization and functional role of phosphodiesterase isozymes in human airway smooth muscle. J. Pharmacol. Exp. Ther. 265:1213-1223.
17. Diamond, L., J. L. Szarek, M. N. Gillespie, and R. J. Altiere. 1983. In vivo bronchodilatory activity of vasoactive intestinal peptide in the cats. Am. Rev. Respir. Dis. 128:827-832.
18. 2α. In S. I. Said, editor. Vasoactive Intestinal Peptide. Raven Press, New York. 185-191.
19. Barnes, P. J., and C. M. S. Dixon. 1984. The effect of inhaled vasoactive intestinal peptide on bronchial reactivity to histamine in man. Am. Rev. Respir. Dis. 130:162-166.
20. Palmer, J. B. D., F. M. C. Cuss, J. B. Warren, and P. J. Barnes. 1986. The effect of infused vasoactive intestinal peptide on airway function in normal subjects. Thorax 41:663-666.
21. Bungaad, A., S. D. Enehjelm, and S. Aggestrop. 1983. Pretreatment of exercise-induced asthma with inhaled vasoactive intestinal peptide. Eur. J. Respir. Dis. 64:427-429.
22. O'Donnell, M., R. J. Garippa, N. Rinaldi, W. M. Selig, B. Smiko, L. Renzetti, S. A. Tannu, M. A. Wasserman, A. Welton, and D. R. Bolin. 1994. Ro25-1553: A novel long-acting vasoactive intestinal peptide agonist. Part 1: in vitro and in vivo bronchodilator studies. J. Pharmacol. Exp. Ther. 270:1282-1288.
23. Dupuy, P. M., S. A. Shore, J. M. Drazen, C. Frostell, W. A. Hill, and W. M. Zapol. 1992. Bronchodilator action of inhaled nitric oxide in guinea pigs. J. Clin. Invest. 90:421-428.